Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

Watch out, Gilead and Novartis: there's a new CAR-T in town. Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl, a late entry to the heated CD19 CAR-T cell therapy ...

Investors interested in Business Services stocks should always be looking to find the best-performing companies in the group. AppLovin (APP) is a stock that can certainly grab the attention of many ...

In the life sciences industry in particular, leading pharma companies are already deploying this technology across their own operations to spur productivity and efficiency for mundane, time ...

People drink takeaway coffee in view of the City of London skyline in London, Britain, July 25, 2024. REUTERS/Hollie Adams/File Photo British public-sector employers now expect to raise pay faster ...

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

From the end of November Market data will no longer be displayed here.